We are live on ! Find out more
KALA icon

KALA BIO
KALA

99 hedge funds and large institutions have $79.4M invested in KALA BIO in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

17% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 23

2% more funds holding

Funds holding: 97 → 99 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

54% less capital invested

Capital invested by funds: $171M → $79.4M (-$91.6M)

57% less call options, than puts

Call options by funds: $388K | Put options by funds: $907K

Holders
99
Holders Change
+2
Holders Change %
+2.06%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
27
Reduced
23
Closed
13
Calls
$388K
Puts
$907K
Net Calls
-$519K
Net Calls Change
-$1.5M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$1M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$621K
3
Renaissance Technologies
Renaissance Technologies
New York
+$578K
4
Millennium Management
Millennium Management
New York
+$432K
5
TCM
Towercrest Capital Management
Pennsylvania
+$423K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$7M
2
UBS Group
UBS Group
Switzerland
-$1.16M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.04M
4
JAM
Jupiter Asset Management
United Kingdom
-$920K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$863K
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
76
Principal Financial Group
Iowa
$32K -$8.63K -1 -17%
Citigroup
77
Citigroup
New York
$31K +$8.63K +1 +25%
ASRS
78
Arizona State Retirement System
Arizona
$30K +$8.63K +1 +25%
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$28K +$25.9K +3 +300%
FNBT
80
FineMark National Bank & Trust
Florida
$26K – – –
KAS
81
Kestra Advisory Services
Texas
$26K – – –
LC
82
Lindbrook Capital
California
$26K – – –
UBS Group
83
UBS Group
Switzerland
$25K -$1.16M -134 -97%
MA
84
MCF Advisors
Kentucky
$22K – – –
EW
85
Evoke Wealth
California
$20K +$25.9K +3 New
Zurich Cantonal Bank
86
Zurich Cantonal Bank
Switzerland
$19K – – –
Walleye Trading
87
Walleye Trading
New York
$18K -$77.7K -9 -75%
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$17K +$8.63K +1 +50%
SPIA
89
Steward Partners Investment Advisory
New York
$16K – – –
TRCT
90
Tower Research Capital (TRC)
New York
$9K -$25.9K -3 -75%
AIP
91
Ameritas Investment Partners
Nebraska
$9K – – –
Canada Life
92
Canada Life
Manitoba, Canada
$7K – – –
JCM
93
Jacobi Capital Management
Pennsylvania
$6K – – –
OPERF
94
Oregon Public Employees Retirement Fund
Oregon
$6K – – –
First Manhattan
95
First Manhattan
New York
$4K – – –
PCM
96
Penserra Capital Management
California
$3K – – –
Wells Fargo
97
Wells Fargo
California
$3K – – –
BCA
98
Berman Capital Advisors
Georgia
$3K +$8.63K +1 New
QT
99
Quantbot Technologies
New York
$2K -$17.3K -2 Closed
CAPTRUST Financial Advisors
100
CAPTRUST Financial Advisors
North Carolina
$1K – – –
1 2 3
4
5

KALA Hedge Fund Activity: Q3 2021 in Review

99 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2021, worth a combined $79.4M — down 54% from $171M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KALA positions and 13 closed out — a net gain of 3 holders — while 27 added to existing stakes and 23 trimmed.

The largest buyer was State Street, adding an estimated $1M. The largest seller was OrbiMed, cutting an estimated $7M.

  • 99 institutional investors held KALA BIO (KALA) as of Q3 2021, up from 97 in Q2 2021.
  • Funds reported $79.4M of KALA BIO stock for Q3 2021, down 54% quarter-over-quarter.
  • 16 funds opened new KALA BIO positions in Q3 2021 and 13 closed out, a net change of +3 holders.
  • The largest KALA BIO buyer in Q3 2021 was State Street, an estimated $1M added.
  • The largest KALA BIO seller in Q3 2021 was OrbiMed, an estimated $7M sold.

Based on aggregated 13F filings for Q3 2021.